Off-label use of drugs in children

Kathleen A. Neville, Daniel A.C. Frattarelli, Jeffrey L. Galinkin, Thomas P. Green, Timothy D. Johnson, Ian Paul, John N. Van Den Anker

Research output: Contribution to journalShort survey

145 Citations (Scopus)

Abstract

The passage of the Best Pharmaceuticals for Children Act and the Pediatric Research Equity Act has collectively resulted in an improvement in rational prescribing for children, including more than 500 labeling changes. However, off-label drug use remains an important public health issue for infants, children, and adolescents, because an over-whelming number of drugs still have no information in the labeling for use in pediatrics. The purpose of off-label use is to benefit the individual patient. Practitioners use their professional judgment to determine these uses. As such, the term "off-label" does not imply an improper, illegal, contraindicated, or investigational use. Therapeutic decision-making must always rely on the best available evidence and the importance of the benefit for the individual patient.

Original languageEnglish (US)
Pages (from-to)563-567
Number of pages5
JournalPediatrics
Volume133
Issue number3
DOIs
StatePublished - Jan 1 2014

Fingerprint

Off-Label Use
Pharmaceutical Preparations
Pediatrics
Decision Making
Public Health
Research
Therapeutics

All Science Journal Classification (ASJC) codes

  • Pediatrics, Perinatology, and Child Health

Cite this

Neville, K. A., Frattarelli, D. A. C., Galinkin, J. L., Green, T. P., Johnson, T. D., Paul, I., & Van Den Anker, J. N. (2014). Off-label use of drugs in children. Pediatrics, 133(3), 563-567. https://doi.org/10.1542/peds.2013-4060
Neville, Kathleen A. ; Frattarelli, Daniel A.C. ; Galinkin, Jeffrey L. ; Green, Thomas P. ; Johnson, Timothy D. ; Paul, Ian ; Van Den Anker, John N. / Off-label use of drugs in children. In: Pediatrics. 2014 ; Vol. 133, No. 3. pp. 563-567.
@article{a0862dcbdf0a4f7bb01f52c239be7574,
title = "Off-label use of drugs in children",
abstract = "The passage of the Best Pharmaceuticals for Children Act and the Pediatric Research Equity Act has collectively resulted in an improvement in rational prescribing for children, including more than 500 labeling changes. However, off-label drug use remains an important public health issue for infants, children, and adolescents, because an over-whelming number of drugs still have no information in the labeling for use in pediatrics. The purpose of off-label use is to benefit the individual patient. Practitioners use their professional judgment to determine these uses. As such, the term {"}off-label{"} does not imply an improper, illegal, contraindicated, or investigational use. Therapeutic decision-making must always rely on the best available evidence and the importance of the benefit for the individual patient.",
author = "Neville, {Kathleen A.} and Frattarelli, {Daniel A.C.} and Galinkin, {Jeffrey L.} and Green, {Thomas P.} and Johnson, {Timothy D.} and Ian Paul and {Van Den Anker}, {John N.}",
year = "2014",
month = "1",
day = "1",
doi = "10.1542/peds.2013-4060",
language = "English (US)",
volume = "133",
pages = "563--567",
journal = "Pediatrics",
issn = "0031-4005",
publisher = "American Academy of Pediatrics",
number = "3",

}

Neville, KA, Frattarelli, DAC, Galinkin, JL, Green, TP, Johnson, TD, Paul, I & Van Den Anker, JN 2014, 'Off-label use of drugs in children', Pediatrics, vol. 133, no. 3, pp. 563-567. https://doi.org/10.1542/peds.2013-4060

Off-label use of drugs in children. / Neville, Kathleen A.; Frattarelli, Daniel A.C.; Galinkin, Jeffrey L.; Green, Thomas P.; Johnson, Timothy D.; Paul, Ian; Van Den Anker, John N.

In: Pediatrics, Vol. 133, No. 3, 01.01.2014, p. 563-567.

Research output: Contribution to journalShort survey

TY - JOUR

T1 - Off-label use of drugs in children

AU - Neville, Kathleen A.

AU - Frattarelli, Daniel A.C.

AU - Galinkin, Jeffrey L.

AU - Green, Thomas P.

AU - Johnson, Timothy D.

AU - Paul, Ian

AU - Van Den Anker, John N.

PY - 2014/1/1

Y1 - 2014/1/1

N2 - The passage of the Best Pharmaceuticals for Children Act and the Pediatric Research Equity Act has collectively resulted in an improvement in rational prescribing for children, including more than 500 labeling changes. However, off-label drug use remains an important public health issue for infants, children, and adolescents, because an over-whelming number of drugs still have no information in the labeling for use in pediatrics. The purpose of off-label use is to benefit the individual patient. Practitioners use their professional judgment to determine these uses. As such, the term "off-label" does not imply an improper, illegal, contraindicated, or investigational use. Therapeutic decision-making must always rely on the best available evidence and the importance of the benefit for the individual patient.

AB - The passage of the Best Pharmaceuticals for Children Act and the Pediatric Research Equity Act has collectively resulted in an improvement in rational prescribing for children, including more than 500 labeling changes. However, off-label drug use remains an important public health issue for infants, children, and adolescents, because an over-whelming number of drugs still have no information in the labeling for use in pediatrics. The purpose of off-label use is to benefit the individual patient. Practitioners use their professional judgment to determine these uses. As such, the term "off-label" does not imply an improper, illegal, contraindicated, or investigational use. Therapeutic decision-making must always rely on the best available evidence and the importance of the benefit for the individual patient.

UR - http://www.scopus.com/inward/record.url?scp=84895182787&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84895182787&partnerID=8YFLogxK

U2 - 10.1542/peds.2013-4060

DO - 10.1542/peds.2013-4060

M3 - Short survey

C2 - 24567009

AN - SCOPUS:84895182787

VL - 133

SP - 563

EP - 567

JO - Pediatrics

JF - Pediatrics

SN - 0031-4005

IS - 3

ER -

Neville KA, Frattarelli DAC, Galinkin JL, Green TP, Johnson TD, Paul I et al. Off-label use of drugs in children. Pediatrics. 2014 Jan 1;133(3):563-567. https://doi.org/10.1542/peds.2013-4060